Vimarsana
Biggest News Aggregation in the World

Pharma Exec News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Exec. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Exec Today - Breaking & Trending Today

Mycovia Pharmaceuticals, Inc. Announces Partner Jiangsu Hengrui Pharmaceuticals Co., Ltd's Approval of Oteseconazole Capsules for the Treatment of Severe Vulvovaginal Candidiasis (VVC) in China - Vimarsana News

Mycovia Pharmaceuticals, Inc. Announces Partner Jiangsu Hengrui Pharmaceuticals Co., Ltd's Approval of Oteseconazole Capsules for the Treatment of Severe Vulvovaginal Candidiasis (VVC) in China

/PRNewswire/ -- Mycovia Pharmaceuticals, Inc. ("Mycovia"), an emerging biopharmaceutical company, today announced that Jiangsu Hengrui Pharmaceuticals Co., Ltd...

Camrelizumab in Combination with Rivoceranib (Apatinib) Significantly Prolonged Overall Survival and Progression-Free Survival vs. Sorafenib in Patients with Unresectable Hepatocellular Carcinoma in a Multinational Phase 3 Trial, a Joint Program with Elev | Antibodies - Vimarsana News

Camrelizumab in Combination with Rivoceranib (Apatinib) Significantly Prolonged Overall Survival and Progression-Free Survival vs. Sorafenib in Patients with Unresectable Hepatocellular Carcinoma in a Multinational Phase 3 Trial, a Joint Program with Elev | Antibodies

Camrelizumab in Combination with Rivoceranib (Apatinib) Significantly Prolonged Overall Survival and Progression-Free Survival vs. Sorafenib in Patients with Unresectable Hepatocellular Carcinoma in a Multinational Phase 3 Trial, a Joint Program with Elevar Therapeutics

Iktos Announces Deployment of Their AI for Drug Design Software Makya by Jiangsu Hengrui Pharmaceuticals Co., Ltd. - Vimarsana News

Iktos Announces Deployment of Their AI for Drug Design Software Makya by Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Iktos, a company specialized in Artificial Intelligence for new drug design today announced recent collaboration agreement in AI for new drug design with Jiangsu Hengrui Pharmaceuticals Co., Ltd., a

Former pharma exec, publicist charged with insider trading - Vimarsana News

Former pharma exec, publicist charged with insider trading

NEWARK, N.J. (AP) — A former executive and and a former communications director at a...

Former pharma exec, publicist charged with insider trading - Vimarsana News

Former pharma exec, publicist charged with insider trading

NEWARK, N.J. (AP) — A former executive and and a former communications director at a...